Blog Posts
Great strategies start with understanding People. Explore our blogs for insights on HCP and Patient intelligence, workforce engagement, data science, and the latest industry news
How the Message Resonance Score™ works?
What is the Message Resonance Score™? The Message Resonance Score™ evaluates alignment between strategic messaging and...
What Is the Message Resonance Score™?
Talking Medicines transforms unstructured, real-life data into actionable intelligence. By combining Advanced Data...
What Does Consumerism in Pharma Actually Mean?
At Talking Medicines, we are increasingly asked about the evolving role of patients in the pharmaceutical landscape...
The Next Frontier in Precision Medicine: The Gut Microbiome
What Is Bioavailability and Why Does It Matter? Bioavailability refers to the proportion of a drug that reaches...
Message Resonance: The New KPI for Client Confidence
What This Means for Agency Leaders Responsible for Client Confidence For a long time, broad messaging strategies...
From Molecule to Outcome: Aligning Therapy Positioning with the Patient Journey
Diagnosis: Anchoring Awareness in Biological Reality Across disease areas with high unmet need, diagnosis is often...
Why the GLP-1 Story Keeps Changing and Why Strategy Leaders Should Pay Attention
GLP-1 receptor agonists (GLP-1s) are evolving quickly, not just in terms of clinical evidence, but in how Healthcare...
The MSL Playbook Is Broken: How Predictive Intelligence Redefines Medical Affairs Execution
Why Medical Science Liaisons need a new operating model and how predictive HCP intelligence turns scientific exchange...
AI: Driving the Future of Life Sciences Beyond 2026
Scotland’s AI Advantage: Why Edinburgh Leads the UK in Healthcare Innovation A recent Deloitte report named Edinburgh...
GLP-1 Receptor Agonists and the Future of Metabolic Health
GLP-1RAs: Rapid Disruption, Regulatory Shifts & The Rise of Intelligent Health Information In less than a...
From Patent Cliffs to Next-Gen Blockbusters: Why 2026 Demands Message Resonance at the Heart of Commercial Strategy
The Pharmaceutical Industry in 2026 stands at a critical inflection point - where scientific promise...
Pharma Marketing Crosses Into Consumer Territory
What JPM 2026 Told Us About GLP‑1s, Oncology and the New Rules of Engagement Pharma marketing has finally crossed a...